Hans-Peter Stoll

Dr. Stoll has served as the Chief Clinical Officer since April 2022, Dr. Stoll is a medical executive with 19 years of business experience in bringing medical innovations to market. He has extensive knowledge in design and execution of clinical strategies and, over the years, has forged strong relationships with global physician opinion leaders.

Previously, Dr. Stoll served as Vice President of International Clinical Affairs & Cardiovascular Research at MCRA, where he led an international team to build MCRA’s cardiovascular CRO as well as integrated regulatory capabilities in Europe. Prior, he was the CMO at Biosensors International where he led a team of 17 people to develop and execute clinical strategies. Dr. Stoll has also served as Chief Medical Officer (CMO) Cardiology for GE Healthcare and was WW Vice President of Clinical Research at Cordis, Johnson & Johnson Company. Dr. Stoll has been extensively published, with over 70 publications in international peer-reviewed medical journals. Dr. Stoll received his medical degree and board certifications in Nuclear Medicine, Internal Medicine, and Cardiology at Saarland University, Germany, completed his Research Fellowship in Cardiology at Indiana University, and earned a Professor of Internal Medicine title from Saarland University in 2005.